Maxime LeMerdy, Ph.D.
Dr. Le Merdy is now a Senior Scientist at Simulations Plus, the world leader company in innovative modeling and simulation software applied to the pharmaceutical research and development. Before joining Simulations Plus, Dr. Le Merdy received a Pharm.D. from University Paris-Descartes in 2015. In 2014, he received his master’s degree in Pharmacometrics from the same university. He joined the FDA in 2017 as a Post-doctoral fellow in the Division of Quantitative Method and Modeling within the Office of Generic Drugs, where he developed his expertise in PBPK models for locally acting drug products and published multiple paper on ocular delivery models. Prior to this experience, he published on Ethyl-glucuronide, a biomarker of alcohol consumption as well as the physiological modification affecting children’s pharmacokinetics.